Skip to main content
. 2022 Jan 12;10(1):e01564-21. doi: 10.1128/spectrum.01564-21

TABLE 1.

Anti-SARS-CoV-2 spike antibody titers for IgG and IgM in the positive samples from three performance evaluation panels

Antibody titer IgG
IgM
Panel 1 Panel 2 Panel 3 Panel 1 Panel 2 Panel 3
100 1 0 0 13 12 11
400 7 6 7 11 11 12
1600 12 12 11 6 6 6
≥6400 10 12 12 0 1 1
Samplesa (n) 30 30 30 30 30 30
a

Samples were tested for anti-SARS-CoV-2 IgG and IgM using CDC ELISA against the spike protein.